RxDoctor Payments Data

Siena Alford, DO

Family Medicine · Conway, SCNPI 1881648319

Payments from drug & device makers

$212in general payments, 2019–2025

Across 13 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$49
  • Takeda Pharmaceuticals U.S.A., Inc.$36
  • Amarin Pharma, Inc.$30
  • Vital Connect, Inc$22
  • Lilly USA, LLC$17
  • Neos Therapeutics, LP$17
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$212100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$212 in reported general payments places this provider in the 35th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$58,756
Medicare patients
162
Services billed
1,091

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol56$63,308
OzempicSemaglutide40$46,465
JanuviaSitagliptin Phosphate17$26,728
XareltoRivaroxaban18$25,267
JardianceEmpagliflozin11$17,931
EliquisApixaban16$14,888
RybelsusSemaglutide11$14,803
TrintellixVortioxetine Hydrobromide11$11,012
BrilintaTicagrelor11$4,763
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$4,552
Rosuvastatin Calcium154$4,043
Levemir FlexpenInsulin Detemir18$3,475
Levothyroxine Sodium148$2,838
Valsartan41$2,798
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide37$2,714

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$14$61,26751 claims
PfizerEliquis$16$14,88816 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$36$11,01211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Conway

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →